Cite
HARVARD Citation
Hooker, A. et al. (n.d.). 104. Process development and cGMP manufacture of a targeted secretion inhibitor: a novel botulinum neurotoxin–based biotherapeutic platform. Toxicon. pp. S32-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hooker, A. et al. (n.d.). 104. Process development and cGMP manufacture of a targeted secretion inhibitor: a novel botulinum neurotoxin–based biotherapeutic platform. Toxicon. pp. S32-. [Online].